BioNexus Gene Lab Corp
BGLC· Nasdaq
BioNexus Gene Lab Corp
- Last sale
- Sep 30, 2026 · -11.27%
- Market cap
- $3.58M
- 2.93M shares
- Filings
- 155
Price
Sep 30, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $7,424,911 | reported | |
| FY 2024 | 2024-12-31 | $9,510,646 | reported | |
| FY 2023 | 2023-12-31 | $9,770,806 | reported | |
| FY 2022 | 2022-12-31 | $10,928,707 | reported | |
| FY 2021 | 2021-12-31 | $13,362,567 | reported | |
| FY 2020 | 2020-12-31 | $11,390,440 | reported | |
| FY 2019 | 2019-12-31 | $126,955 | reported | |
| FY 2018 | 2018-12-31 | $212,328 | reported |
BioNexus Gene Lab Corp · CIK 1737523 · Engraved from SEC EDGAR
